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Abstract
Background: Identification of the early signs of schizophrenia would be a major achievement for the early intervention
and prevention strategies in psychiatry. Social impairments are defining features of schizophrenia. Impairments of
individual layers of social competencies are frequently described in individuals with 22q11.2 deletion syndrome (22q11.
2DS), who have high risk of schizophrenia. It is unclear whether and to what extent social impairments associate with
subclinical negative and positive symptoms in 22q11.2DS, and which layer of social impairments are more correlated
with schizophrenia-related symptoms. The aims of this study were to conduct a comprehensive investigation of social
impairments at three different levels (function, skill, and cognition) and their interrelationship and to determine to what
degree the social impairments correlate to subclinical levels of negative and positive symptoms, respectively, in a young
cohort of 22q11.2DS not diagnosed with schizophrenia.
Methods: The level of social impairment was addressed using questionnaires and objective measures of social
functioning (The Adaptive Behavior Assessment System), skills (Social Responsiveness Scale), and cognition (The
Awareness of Social Inference Test and CANTAB Emotional Recognition Task), and the presence of subclinical
symptoms of schizophrenia were evaluated using the Structured Interview for Prodromal Syndromes in a cross-sectional
case-control study of 29 cases and 29 controls, aged 12 to 25 years. Association between social impairment and negative
and positive symptoms levels was examined in cases only.
Results: Subjects with 22q11.2DS were highly impaired in social function, social skills, and social cognition (p ≤ 6.2 × 10−9)
relative to control peers and presented with more negative (p = 5.8 × 10−11) and positive (p = 7.5 × 10−4) symptoms.
In particular, social functional and skill levels were highly associated with notably subclinical negative symptoms levels.
Conclusions: This study shows strong correlations between levels of social impairments and subclinical negative and
positive symptoms. However, longitudinal studies are required to show if social impairments represent early disease
manifestations. If parental or self-reporting suggests severe social impairment, it should advocate for clinical awareness
not only to social deficits per se but also of potential subclinical psychosis symptoms.
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Background
The 22q11.2 deletion syndrome (22q11.2DS) results from
a hemizygous deletion on chromosome 22q11.2 and is the
most common microdeletion syndrome in humans, with
an estimated prevalence of 1:4000 [1, 2]. The syndrome is
associated with a variety of clinical manifestations of
highly variable expressions [3] including a high prevalence
of psychiatric disorders. Notably, schizophrenia spectrum
disorders are seen in up to 41% of the clinically identi-
fied adult 22q11.2 deletion carriers [4–9], and large
cross-sectional case-control studies in schizophrenia
have reported odds ratio estimates for the 22q11.2 dele-
tion between 15 and 44 [10–13]. Moreover, an epi-
demiological population study has shown that the risk
of schizophrenia spectrum disorders among persons di-
agnosed with 22q11.2DS is approximately eight times
the risk of the general population [14].
The clinical presentation of schizophrenia in 22q11.2DS
has considerable overlap with clinically defined idiopathic
forms of schizophrenia [7, 15] and as such, 22q11.2DS
may represent a biological homogeneous “at risk group”,
that can further the understanding of both the behavioral
and biological mechanisms underlying development of
schizophrenia in the general population. Also, since more
22q11.2 deletion carriers are being identified at a young
age, they may provide insights into the early signs of
schizophrenia pathology.
Social impairments are core features of schizophrenia
[16] and can be categorized into three multidimensional
constructs, nested within each other. The most narrow
construct can be defined by social cognitive deficits,
which underlie the more widely concept of social skills
that again contributes to the broad construct of social
function [17]. “Social cognition” refers to the mental pro-
cesses involved in perceiving, attending to, remembering,
thinking about, and making sense of the people in our so-
cial world [18] and includes emotional processing and the-
ory of mind (ToM) [19]. “Social skills” refers to verbal and
non-verbal behaviors with complex cognitive abilities
necessary to engage in successful interpersonal interac-
tions (e.g., initiating a conversation) [20, 21]. Lastly, “social
function” is operationalized in a variety of ways, encom-
passing performance across everyday domains (e.g., inde-
pendent living, employment, interpersonal relationships,
and recreation) [22].
The reported social impairments in schizophrenia in-
clude social cognitive functions [23–29], social skills
[30, 31], and social functioning [31–33]. In particular,
diminished everyday functioning and social skills are
associated with negative rather than positive symptoms
in schizophrenia [31, 34]. Similar results have been
reported for a group of children and adolescents (age
12–18 years) at clinical high risk for schizophrenia pre-
senting with either prodromal or transient and recent-
onset psychotic symptoms; a recent drop in daily func-
tioning combined with schizotypal personality disorder
or a first degree relative with a psychotic disorder [35].
Moreover, the Dutch Genetic Risk and Outcome in
Psychosis (GROUP) study has shown correlations be-
tween measures of social cognitive impairments (i.e.,
The Degraded Facial Affect Recognition task) and nega-
tive symptoms severity in both patients with non-
affective psychotic disorders and subclinical negative
symptoms in their healthy siblings. This finding may
suggest that there is a common origin of the social cog-
nitive functions and negative symptoms [23].
Previous studies have reported that children and ado-
lescents with 22q11.2DS have impairments in social
functioning [36, 37], social skills [38], and social cogni-
tion, e.g., [38–41]. Diminished ToM has previously been
reported to associate with the severity of psychotic
symptoms in adolescences with 22q11.2DS [42] and,
Chow and collaborators [43] found more impairments of
ToM among 22q11.2DS adults with schizophrenia com-
pared to 22q11.2DS adults without psychosis. However,
there is still limited knowledge on the inter-relationship
between different layers of social competences in
22q11.2DS and how impairments in the individual layers
of the social competences relate to symptoms of schizo-
phrenia in young 22q11.2 deletion carriers.
The aims of this study were twofold; to characterize
impairments across social functioning, skills, and cog-
nition and their inter-relationship in 22q11.2 deletion
carriers who are at risk for developing schizophrenia
and to investigate the strengths of correlation between
these different layers of social impairments and sub-
clinical levels of negative and positive symptoms in a
young 22q11.2DS cohort without schizophrenia. We
expected that the 22q11.2DS group would show defi-
cits at all three layers of social competence that the
different measures of social competences were inter-
correlated and that the level of social impairments as-




The study applies two different study designs. First, to
document the level of overall social impairments, their
inter-relationship, and examine the amount of psycho-
pathology within the 22q11.2DS group, we used a
cross–sectional case–control design in which each
22q11.2DS person was individually matched on sex and
age with a non-related control individual. Second, we
applied a case-only design to test for associations be-
tween the degree of social impairments and the levels
of psychopathology.
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Participants
The total sample consisted of 29 clinically identified sub-
jects with 22q11.2DS in whom the deletion was verified
by SNP array analysis (Human OmniExpress BeadChip
Illumina) and 29 control individuals. Based on the clin-
ical diagnoses reported in the comprehensive Danish
health registries, we have previously shown that the
recruited cases represent the entire cohort of people di-
agnosed with 22q11.2DS in Denmark [44]. Current diag-
noses of affective disorder, anxiety, and disturbance of
activity and attention/attention–deficit disorder without
hyperactivity were provided by the use of the Mini Inter-
national Neuropsychiatric Interview [45] or the Mini
International Neuropsychiatric Interview for Children
and Adolescents [46]. The current diagnosis of schizo-
phrenia was obtained from the Structured Interview for
Prodromal Syndromes [47], and IQ below 70 determined
from Reynolds Intellectual Screening Test (RIST) [48]
was used as an indication of current intellectual disabil-
ity. We used the clinical threshold of 15 derived from
the Social Communication Questionnaire lifetime form
[49, 50] to indicate the presence of current autism
spectrum disorders. Lifetime diagnoses for psychiatric
disorders were obtained from the Danish Psychiatric
Central Register that holds information on all Danish
psychiatric inpatient facilities since April 1, 1969, and
for outpatient facilities since 1995 [51]. The diagnoses in
Denmark are assigned according to the International
Classification of Diseases (ICD) system, and as outlined
by several investigators, the validity of the register
diagnoses is good [52–54]. In Denmark, every citizen
has a unique civil registration number, which is given at
birth or upon immigration [52]. This civil registration
number can be linked to information recorded in the
Danish Psychiatric Central Register, which automatically
obtains records on all clinical discharge diagnoses given
in Denmark [55]. Since health care is free of charge, all
Danish citizens can get treatment for all their illnesses.
This ensures that the psychiatric registry reflects the disor-
ders that Danish citizens are treated for during their
lifetime. The sample characteristics are shown in Table 1.
Recruitment
All participants were enrolled in the Danish research ini-
tiative of 22q11.2DS [44]. The individuals with 22q11.2DS
were recruited from the Pediatric Department, Aarhus
University Hospital, Clinical Genetic Department of
Rigshospitalet, Copenhagen, or the Danish National
22q11.2DS Association. The two clinical departments are
non-specialty clinics, which monitor healthcare and/or so-
cial community issues. When clinical healthcare is needed,
patients are referred to specialized clinics for treatment.
Cases that had a prior or current clinical diagnosis of
schizophrenia according to ICD-10 diagnostic criteria
were not enrolled. Unrelated control participants were re-
cruited either by letter through the National Danish Civil
Registry, via public postings on www.forsøgsperson.dk, or
among children of participants in the Danish Blood Donor
Study. Control individuals fulfilling the criteria for psychi-
atric disorders including schizophrenia spectrum (ICD10
Table 1 Demography, lifetime and current history of psychiatric disorders
22q11.2DS (n = 29) Controls (n = 29)
Mean age (SD) 15.7 (2.8) 16.0 (2.8)
Male/female ratio 19:10 19:10
Caucasian ancestry 29 29
3 megabase deletion 29 0
Intelligence quotient (range)a 79.52 (35–113) 108.76 (87–129)
Psychiatric diagnoses % Lifetimeb Currenta–e Lifetimeb Currenta–e
Schizophrenia spectrum disorders (F2x)c 0 0 0 0
Affective disorders (F30-F33)d 3.4 3.4 0 0
Anxiety and phobia (F4x)d 3.4 34.5 0 13.8
Intellectual disability (F7x)a 17.2 20.1 0 0
Autism spectrum disorders (F84.x)e 13.8 13.8 0 0
Disturbance of activity and attention/attention-deficit disorder without
hyperactivity (F90.0/98.8C)d
3.4 3.4 0 0
aIntelligence quotient score was derived from the Reynolds Intellectual Screening Test (RIST) [48]. Indication of current intellectual disability was indexed by RIST
IQ below 70
bLifetime diagnoses according to International Classification of Diseases (ICD-10) obtained from the Danish Psychiatric Central Register [51]
cCurrent diagnosis of schizophrenia was obtained from the Structured Interview for Prodromal Syndromes
dCurrent diagnoses of affective disorder, anxiety, and disturbance of activity and attention/attention-deficit disorder without hyperactivity were provided by use of
the Mini International Neuropsychiatric Interview [45, 82] or the Mini International Neuropsychiatric Interview for Children and Adolescents [46]
eIndications of current autism spectrum disorders (ASD) was determined from parental reporting using the Social Communication Questionnaire lifetime form.
Clinical cut-off of 15 indicates ASD [49, 50]
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DF20-29); bipolar affective (ICD10 DF30-31); depression
(ICD DF32-33); and autism spectrum disorders (ICD10
DF84); and substance abuse (ICD10 DF10); according to
ICD-10 criteria were excluded based on life time history
of psychiatric disorders obtained from the Danish Health
Registries and current state presentation of symptoms
evaluated as described above.
Measures
Schizophrenia symptoms
The Structured Interview for Prodromal Syndromes
(SIPS) [47] was part of a larger examination battery for
psychopathology [44] and used to rate the severity of 19
schizophrenia-related symptoms. SIPS ratings are given
on a 0–6 point scale within four domains: positive, nega-
tive, disorganized, and general symptoms. A rating of zero
represents absence of symptoms, and six refers to ex-
tremely severe level of symptoms. Ratings of 3–5 are
within the attenuated range [56]. In the current study, we
focused on the positive and negative symptoms scores.
The positive symptoms score is a composite measure
obtained by ratings of five items: delusional ideas, perse-
cutory ideas, grandiosity, hallucinations, and disorga-
nized communication. The negative symptoms score is a
composite measure including six items: anhedonia or
withdrawal, avolition, decreased expression of emotions,
decreased experience of emotion or self, impoverished
thinking, and deterioration of role functioning. The dis-
organized composite score includes odd behavior and
appearance, bizarre thinking, trouble with focus and at-
tention, and personal hygiene (total raw composite score
range 0–24). The generalized composite score defines
odd behavior and appearance, bizarre thinking, trouble
with focus and attention, and personal hygiene (total
raw composite score range 0–25). We used the raw sum
of positive (score range 0–30) and negative (score range
0–36) symptoms scores as separate dimensional mea-
sures of psychotic symptoms. The SIPS interview was
conducted by two experienced and SIPS certified clini-
cians (AV and HS) who demonstrated good inter-rater
reliability (k = 0.73).
Intellectual functioning
Reynolds Intellectual Screening Test (RIST) [48] was
used to assess the intelligence level. The RIST consists
of (1) a verbal “guess what” subtest where the guess is
based on subject cues and (2) a non-verbal “odd item
out” subtest (i.e., which figure does not fit in according
to classifications or spatial relations). Questions/figures
are given from floor level in order of increasing diffi-
culty until three consecutive failures are obtained. The
intelligence quotient (IQ) was based on the sum of the
two subtest T scores derived from Danish test norms
provided by the publisher.
Social functioning
The Adaptive Behavior Assessment System—Second
Edition (ABAS-II) [57], which assesses adaptive func-
tioning, was used as to assess the general everyday func-
tioning whereas the social subdomain was used as an
index of social functioning. Adaptive functioning entails
the daily activities required for personal and social suffi-
ciency defined by the expectations or standards of other
people [58]. Parents or daily caretakers were respondents
for participants under 18 years of age. The questionnaire
was self-administered for participants over 18 years
(with aid from a caretaker if necessary). A general adap-
tive composite score (ABAScomposite), which includes
three subdomains: conceptual, social, and practical was
derived from raw scores of the nine sub-scales in ABAS-
II and the social subdomain raw score (ABASsocial)
specifically address the functioning in social and leisure
situations. Danish norms do not exist, but ample reliabil-
ity and validity data are included in the Danish version
of the ABAS-II manual ([59], page 372).
Social skills
Parent ratings of the Social Responsiveness Scale (SRS)
[60] were used to assess social skills. SRS is a 65-item
questionnaire on social behavior the past 6 months,
which focuses on the ability to perceive and process so-
cial information and respond appropriately in interper-
sonal interactions [60]. SRS applies a 4-point Likert scale
(0 = not true, 1 = sometimes true, 2 = often true, 3 = al-
most always true) to rate how often the subject engages
in specific social and communicative behaviors. SRS pro-
vides an overall raw-score (SRStotal). This scale has previ-
ously shown discriminant validity at the group level in
Danish case–control studies of autism [61, 62].
Social cognition—theory of mind (ToM)
The Danish translation of the Awareness of Social Infer-
ence Test—Part A2 Social Inference minimal (TASIT)
[63–65] was used to test for ToM abilities, which has
shown discriminant validity at the group level in a Da-
nish schizophrenia case–control study [63]. TASIT is
composed of 15 video clips showing professional actors
performing everyday interactions using sincere, simple,
and paradoxical sarcasm. Sincere clips show congruence
between what is literally said and the accompanying
paralinguistic and facial cues. Simple sarcastic clips show
incongruence between the spoken word and paralinguis-
tic and facial cues and can only be understood if cues
are correctly interpreted and contradictions are recog-
nized. Correct interpretation of the paradoxical sarcastic
clips requires the ability to understand paralinguistic
cues facial expressions, tone of voice, gesture, etc. [64].
Each film clip is followed by four questions addressing
different aspects of the communicative intentions of the
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persons (what they were doing, saying, thinking, and
feeling). The maximum total TASIT score (TASITtotal) is
60 (ranging from 0–20 for each type of interaction; sin-
cere, simple, and paradoxical sarcasm).
Social cognition—emotion recognition
The Emotion Recognition Task (ERT) from the Cambridge
Neuropsychological Test Automated Battery [66] was used
to test subject’s ability to recognize emotions in facial ex-
pressions. The ERT consists of computer-morphed images
of facial features from a real individual showing specific
emotions. Each participant was shown 90 images in
total, displayed for 200 ms, and followed by an immedi-
ate mask stimulus. The participant then chose which
emotion (i.e., sadness, fear, disgust, happiness, surprise,
and anger) best described the displayed emotion. The
outcome measures are percentage correctly identified
emotions for the each of the six individual emotions,
together with a total percent score (ERTtotal).
Statistical analyses
All statistical analyses were performed using R version
3.2.2 [67]. Normal distribution and homogeneity of vari-
ances were evaluated from histograms, Shapiro–Wilk
normality test and Levene’s test, respectively. Additional
assumptions for ANCOVA and regression analysis were
examined as follows: (a) linearity of the relationship be-
tween the functional measures and covariate or symp-
tom level was seen from examination of scatter plots, (b)
independence and normality of error terms was sup-
ported by inspections of histograms and P–P plot of the
residuals, (c) homoscedasticity was inferred from resid-
uals plots, (d) homogeneity of regression slopes were ex-
amined by evaluation of the pairwise interaction terms
group*sex, age*sex, and age*group and accepted in the
absence of an significant interaction, and (e) absence of
multicollinearity was determined by (i) pairwise correla-
tions with r < 0.8, (ii) tolerance measures T > 0.2, and (iii)
variance inflation factors (VIF) <10.
Two-tailed independent sample t test and chi-squared
test were used to compare the basic demographic factors
(age, sex, and IQ) and between groups.
Case–control comparisons
The total raw scores of ABAScomposite, ABASsocial, SRStotal,
TASITtotal, and ERTtotal were transformed into z-scores,
using the mean and standard deviation from the control
group. A negative z-score for ABAScomposite, ABASsocial,-
TASITtotal, and ERTtotal and a positive z-score for SRStotal
indicates that 22q11.2DS cases performed worse than the
average control individual. Missing values reduced sample
size for the 22q11.2DS and control groups across do-
mains; ABAScomposite and ABASsocial(n = 27 and 28);
SRStotal (n = 25 and 28); TASITtotal (n = 28 and 29);
ERTtotal (n = 28 and 29).
To comply with the requirement for normal distribu-
tion, SIPS scores for all four subdomains were square
root transformed. However, only SIPS data for negative
and positive were normally distributed and only in the
22q11.2DS group. Therefore, we used Wilcoxon rank-
sum test to test for case–control differences in SIPS
scores. Sensitivity analyses were performed post hoc to
address if 22q11.2DS participants with attenuated symp-
toms (n = 6) were driving group differences.
We used two-way ANCOVA to test the main effect
of ABAScomposite, ABASsocial, and ERTtotal using their
z-score as dependent variable, participant (22q11.2 de-
letion carrier or control subject), sex as factor, and age
as covariate. SRStotal and TASITtotal did not meet the
assumptions of normal distribution and homogeneity
of the variances. Therefore, we applied Wilcoxon rank-
sum test to test for group differences (22q11.2DS versus
control subjects) and sex differences. A p value of 0.007
corresponds to Bonferroni adjustment for multiple testing
of the seven group comparisons. Age effects of SRStotal
and TASITtotal were addressed using Spearman’s correl-
ation analysis. Wilcoxon rank-sum test was applied for
post hoc analyses of group differences in subdomains for
TASIT and ERT and to test for differences in the ratings
and test scores between the 22q11.2DS individuals with
and without IQ <70 as an index of intellectual disability.
Pearson’s product-moment correlation or Spearman’s
rank correlation rho analyses were used to test for sig-
nificant inter-correlations between the four measures of
social impairments (ABASsocial, SRStotal, TASITtotal, and
ERTtotal) and to explore the possible effect of IQ and
ABAScomposite on the individual performance in the four
separate measures. Spearman’s rank correlation was used
when one of the pairwise measures did not meet the
assumptions of normality and/or homoscedasticity (i.e.,
SRStotal and TASITtotal). These analyses were conducted
separately for the case and the control groups.
Case-only analyses
The relationship between social competences and nega-
tive and positive symptom levels was independently
accessed within the 22q11.2DS cohort only using linear
regression analyses. Disorganized and generalized
symptoms were sparse and therefore not assessed.
Square root transformed total negative and positive
symptoms were treated as dependent variables and cen-
tralized z-scores derived for measures of ABASsocial,
SRStotal, TASITtotal, or ERTtotal were included as pre-
dictor variables. The centralized z-scores were based on
the mean and standard derivation within the 22q11.2DS
group. The basic model included age, sex, and IQ and
served as offset for four separate extended models for
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negative symptoms that a part from age, sex, and IQ also
included centralized z-scores for ABASsocial, SRStotal,
TASITtotal, or ERTtotal, respectively. Two extended models
that included both ABASsocial and SRStotal and ABASsocial
and TASITtotal, respectively, were also investigated. Only
three separate models for positive symptoms, which in-
cluded age, sex, IQ and either centralized z-scores for
ABASsocial, SRStotal, and TASITtotal were evaluated, as
ERTtotal did not meet the assumption for linearity with
positive SIPS scores. If the individual model was overall
significant, we used analysis of variance to examine if this
model explained significantly more of the variation in
SIPS scores compared to a reduced model that include
age, sex, and IQ or age, sex, IQ, and ABASsocial in the case
of the extended models. Bonferroni-corrected significance




There was an overall nominally significant sex difference
in mean age (t(56) = 2.2, p = 0.03). The 22q11.2DS group
had mean IQ well below the general population mean
and differed significantly from the mean IQ in the con-
trol subjects (t(56) = 7.4, p = 2.14 × 10−10). A total of six
individuals with 22q11.2DS had IQ below 70 but within
the mild (IQ 50–69) to moderate range (IQ 35–49). The
22q11.2DS cohort presented with reduced everyday
functioning as indicated by a mean ABAScomposite rating,
which were more than two standard derivations below
the mean of the control group. There was a significant
group F(1,51) = 62.3, p = 2.14 × 10−10, age F(1, 51) = 20.9,
p = 3.16 × 10−5, and sex F(1, 51) = 9.8, p = 0.003 effect for
ABAScomposite ratings. Table 1 shows that there was
consistency between the lifetime and current prevalence
of all psychiatric disorders but anxiety and phobias. This
is due to the presence of specific phobias (e.g. arachno-
phobia) in both cases and control individuals, which
people rarely seek health care for.
Schizophrenia-related symptomatology
Overall, the 22q11.2DS cohort had significantly ele-
vated mean SIPS scores for negative, positive, and dis-
organized but not generalized symptoms, relative to
control peers (Table 2). The majority of the individuals
with 22q11.2DS (n = 27) had negative symptoms
scores of two standard derivations above the mean of
the control group, and six of these individuals pre-
sented at least one attenuated psychotic symptom (i.e.,
SIPS score above three in one or more positive sy-
mptoms). Only three individuals with 22q11.2DS
presented with elevated disorganized symptoms. A
sensitivity analysis leaving out the six individuals with
attenuated positive symptoms provided similar nom-
inal significant between-group difference for negative
(W = 657, p = 6.51 × 10−10, positive (W = 459, p = 0.01),
disorganized (W = 566, p = 6.35 × 10−7) as well as gen-
eralized (W = 355, p = 0.60) symptom scores.
Table 2 Characteristics of negative and positive SIPS scores and social competences in 22q11.2DS and control peers
22q11.2DS Control Main effect of group
Test Median or mean (SD) Min-max Median or Mean (SD) Min-max za W or F(df,df) p
Psychopathology
Positive symptomsb 3 0–12 0 0–9 625 7.5 × 10−4
Negative symptomsb 6 1–17 0.38 0–2 831 5.8 × 10−11
Disorganized symptomsb 1 0–9 0 0–2 723.5 1.2 × 10−07
General symptomsb 0 0–7 0 0–4 469.5 0.32
Social functioning
ABASsocial
c 99.89 (18.6) 256–606 126.1 (9.26) 110–138 −2.77 61.02 (1,50) 2.9 × 10−10
Social skills
SRStotal
b 64 15–122 15.17 3–44 5.00 678 6.2 × 10−9
Social cognition
TASITtotal
b 38 16–56 52.83 37–58 −3.83 44.5 8.0 × 10−9
ERTtotal
c 40.83 (12.09) 16.67–64.44 64.52 (7.75) 47.67–77.78 −2.96 88.07 (1,53) 7.39 × 10−13
Measures of psychopathology were obtained from the structured interview for prodromal syndromes (SIPS), The raw score obtained from the social domain of the
Adaptive Behavior Assessment System (ABAS-II) was used as a measure of social function, social skills were the total score obtained from the Social
Responsiveness Scale (SRS), social cognitive abilities were evaluated using total correct answers from The Awareness of Social Inference Test (TASIT) and the
CANTAB Emotional Recognition Task (ERT)
aMean z-scores for 22q11.2 group as calculated from mean control = 0 and SD = 1
bGroup median reported; group differences determined from Wilcoxon rank-sum test
cGroup mean reported, main effect of group accessed from two-way ANCOVA [between-group factor (22q11.2DS, controls); between subject’s factor: sex; covariate: age]
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Social competence, age, and sex
The 22q11.2DS cohort was significantly impaired on all
measures of social function, skills, and cognition, relative
to the control group (Table 2).
The 22q11.2DS group had mean ratings and scores of
more than two standard derivations below the mean of
the control individuals for both ABASsocial and ERTtotal.
There was a statistically significant main effect of group
as determined by two-way ANCOVA for ABASsocial and
ERTtotal (Table 2) as well as a significant effect of age,
F(1, 51) = 10.8, p = 0.002, and sex F(1, 51) = 14.90, p =
0.003 for ABASsocial ratings. There was also a significant
main effect of age, F(1, 53) = 10.58, p = 0.002 but not sex
F(1,53) = 3.26, p = 0.08 in ERTtotal scores. There was no
pairwise interaction between age, sex, and group for ei-
ther ABASsocial or ERTtotal (p > 0.05). Post hoc analyses
showed that relative to the control group, the 22q11.2DS
group was significantly less accurate in detecting the
ERT subdomains of feelings of sadness, fear, disgust,
anger, and happiness but not surprise (Table 3).
Wilcoxon rank-sum tests showed statistical significant
differences in SRStotal and TASITtotal scores between the
22q11.2DS and control group (Table 2).
Post hoc analysis revealed that all three types of social
interactions accessed using TASIT (i.e., sincere, simple
sarcasm, and paradoxical sarcasm) were significantly im-
paired in the 22q11.2DS group compared to the control
group (Table 3).
Spearman’s correlation analysis showed an age-related
trend in SRStotal ratings (rs = −0.38, p = 0.053) and TASIT-
total scores (rs = 0.35, p = 0.07) in the 22q11.2DS but not in
the control group (SRStotal: rs = −0.14, p = 0.48; TASITtotal:
rs = 0.21, p = 0.29). Using Wilcoxon rank-sum test, we
found no sex differences in either SRStotal ratings
among 22q11.2DS (W = 357, p = 0.83) or control indi-
viduals (W = 75, p = 0.63). Likewise, there were no sex
differences in TASITtotal scores within the 22q11.2DS
cohort (W = 73, p = 0.43) or the control group (W = 85.5,
p = 0. 68).
Inter-relationship between the three layers of social
competencies
Spearman’s correlation analysis showed significant corre-
lations between the ABASsocial and SRStotal ratings in
both the 22q11.2DS (rs = −0.78, p = 3.174 × 10
−6) and the
control group (rs = −0.53, p = 0.003). Nominally, signifi-
cant pairwise correlations were also seen between ERTtotal
and the TASITtotal score within the 22q11.2 deletion car-
riers (rs = 0.37, p = 0.053) but not within the control indi-
viduals (rs = 0.00, p = 0.99). There were no significant
correlations between ABASsocial or SRStotal and TASITtotal
or ERTtotal (rs < 0.3, p > 0.05).
Explorative analyses of social competencies, everyday
functioning, and IQ
We used explorative pairwise correlation analyses to ex-
plore if the social impairments across the different layers
were related to overall everyday functioning (ABAScomposite)
and IQ. Spearman’s correlation analysis showed significant
correlations between the ABAScomposite and SRStotal ratings
in both the 22q11.2DS (rs = −0.79, p = 1.37 × 10
−6) and the
control group (rs = −0.48, p = 0.008). Pearson’s correlation
analysis showed a strong inter-relationship between ABAS-
composite and ABASsocial in both groups (22q11.2DS: r = 0.84,
p value = 4.48 × 10−8; controls: r = 0.86, p = 1.78 × 10−9).
There was a trend in the pairwise correlations between
ABAScomposite ratings and the ERTtotal score among the
control individuals (r = 0.35, p = 0.07) but not the 22q11.2
deletion carriers (r = 0.19, p = 0.34).
Explorative correlation analysis showed that ERTtotal
(r = 0.43, p = 0.02) but not TASITtotal (rs = 0.16, p = 0.41),
SRStotal (rs = −0.02, p = 0.92), or ABASsocial (r = −0.04,
p = 0.86) correlated significantly with IQ in the
22q11.2DS group. Within the 22q11.2DS cohort, there
were no significant differences in mean test score of
the four independent measures of social competence
when we stratified the group into those with IQ below
and above 70, respectively (p > 0.05). Similar results
were obtained for the control group in which IQ did
not correlate with either SRStotal (rs = −0.15, p = 0.42), or
ABASsocial (r = 0.02, p = 0.91); but there was a trend in the
correlations between IQ and ERTtotal (r = 0.35, p = 0.06). In
contrast to the findings in the 22q11.2DS group, there was
a nominal significant correlation between IQ and TASITtotal
among the control individuals (rs = 0.41, p = 0.03).
Associations between social competence and negative
and positive symptoms in 22q11.2DS case-only analyses
Linear regression analyses revealed an overall significant
effect of the age, sex, and IQ corrected models on
Table 3 Impairments in subdomains of social cognitive
functions in 22q11.2DS relative to controls
Wa p value
ERT subdomains
Disgust 44 6.77 x10−9
Sadness 90.1 4.44 × 10−7
Anger 96 5.95 × 10−7
Happiness 189 5.0 × 10−4
Fear 197 8.0 × 10−4
Surprise 340 0.3
TASIT subscales
Paradoxical sarcasm 53 5.55 × 10−8
Simple sarcasm 84.5 1.16 × 10−6
Sincere 167.5 6.0 × 10−4
aGroup differences determined from Wilcoxon rank-sum test
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negative SIPS symptoms, which individually included
ABASsocial, SRStotal, and TASITtotal and a nominally sig-
nificant effect of the model including the ERTtotal score
(Table 4) within the 22q11.2DS cohort. The analysis of
variance showed that the full models that included
ABASsocial, SRStotal, and TASITtotal explained a signifi-
cant fraction of the variation in negative symptoms than
the basics models alone (Table 4) whereas the model
that included ERTtotal did not. Table 4 shows that there
was an independent significant effect of ABASsocial,
SRStotal ratings, and TASITtotal but not age and sex on
the 22q11.2DS cohort.
Moreover, there was a significant effect of IQ in the
models that included ABASsocial, SRStotal, and TASITtotal.
An extended model that included both ABASsocial and
TASITtotal (F = 5.82; p = 0.03), but not a model that in-
cluded both ABASsocial and SRStotal (F = 2.31; p = 0.14),
explained nominally 10% more (r2 = 0.52) of the vari-
ation in negative SIPS symptoms than the model includ-
ing ABASsocial alone (r
2 = 0.42).
Separate linear models including ABASsocial or SRStotal
explained a nominal significant part of the variance in
the positive symptoms seen among the 22q11.2 deletion
carriers (Table 4). In these two models, ABASsocial and
SRStotal ratings contributed significantly to the model,
and there was a nominal effect of IQ, age and sex
(Table 4). However, the results did not survive correc-
tion for multiple testing.
Discussion
To the best of our knowledge, this is the first study that
examines multiple layers of social impairments in the
same cohort of young 22q11.2 deletion carriers, the
pairwise interrelationship between the different layers of
social impairments, and their relationship with
schizophrenia-related symptoms. We found impairments
across all layers of social competences in this young
non-psychotic 22q11.2DS cohort, and as anticipated, we
saw that the level of impairment in each social layer was
associated with the severity of predominately subclinical
negative symptoms.
Social impairments within and across different layers
In line with previous studies of 22q11.2DS, we found
strong deficits in social function [36, 37, 68] and social
skills [69, 70]. With a mean total SRS score of 64, we
saw the same magnitude of impairment’s for comparable
age groups as that previously reported by Ho and
Table 4 Linear models for negative and positive symptoms: the effect of social function, skills, and cognition adjusted for
age, sex, and IQ
Negative symptoms Positive symptoms
Model ABAS SRS TASIT ERT ABAS SRS TASIT
Intercept Estimate 3.90 3.55 3.66 4.18 2.17 1.81 1.95
T 4.90 4.34 4.22 4.17 1.73 1.37 1.45
Pr(>|t|) 6.76 × 10−5 0.0003 0.0003 0.0004 0.1 0.18 0.16
Age Estimate 0.04 0.06 0.03 −0.01 0.17 0.19 0.11
T 0.88 1.25 0.71 −0.20 2.20 2.23 1.43
Pr(>|t|) 0.39 0.22 0.48 0.84 0.04 0.04 0.17
Male sex Estimate −0.35 −0.05 0.02 0.002 −1.18 −0.82 −0.54
T −1.21 −0.21 0.08 0.006 −2.61 −1.98 −1.37
Pr(>|t|) 0.24 0.84 0.94 0.99 0.02 0.06 0.18
IQ Estimate −0.02 −0.03 −0.02 −0.02 −0.03 −0.03 −0.02
T −3.09 −3.33 −2.94 −2.16 −2.63 −2.70 −2.03
Pr(>|t|) 0.005 0.003 0.007 0.04 0.02 0.01 0.05
Social measure Estimate −0.51 0.52 −0.38 −0.19 −0.64 0.63 −0,25
t −3.67 3.78 −2.86 −1.23 −2.93 2.89 −1.18
Pr(>|t|) 0.001 0.001 0.009 0.23 0.008 0.009 0.25
Full modela Rb 0.42 0.44 0.39 0.22 0.29 0.28 0.15
F (df) 5.71 (4,22) 5.93 (4,21) 5.28 (4,23) 2.92 (4,23) 3.60 (4,22) 3.47 (4,21) 2.17 (4,23)
P 0.003 0.001 0.004 0.04 0.02 0.03 0.10
Basica vs. full modelb F 13.44 14.31 8.18 1.51 8.59 8.38 1.38
p 0.001 0.001 0.009 0.23 0.008 0.009 0.25
aFull model: SIPS score = age + sex + IQ + social measure (i.e., ABASsocial, SRStotal, TASITtotal, or ERTtotal)
bBasic model: SIPS score = age + sex+ IQ
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collaborators (mean SRS total score of 66–72). In con-
trast to our expectations, the inter-relationship among
the measures varied and only the measures of social
function and social skills were highly correlated. Hence,
our results suggest that deficits in other cognitive func-
tions than emotional recognition and ToM are also im-
portant for the more global social skills and functional
abilities. The lack of strong correlations between the
four social test variables and everyday functioning and
IQ, respectively, indicated that overall, the social impair-
ments across the different layers of interest were not
solely accounted for by the overall reduced everyday
(ABAScomposite) or intellectual (IQ) functioning within
our 22q11.2DS cohort.
Social impairments and negative and positive symptoms
Our data showed that 22q11.2 deletion carriers who had
worse social functioning (i.e., those who had lower rat-
ings on ABASsocial) and who had worse social skills (i.e.,
higher SRStotal ratings) had significantly more subclinical
negative and positive symptoms. Notably, the ratings of
social functioning and social skills emerged as those
most associated to both negative and positive symptoms,
which is consistent with findings in clinical high-risk
subjects [31]. Social functioning has previously been
shown to deteriorate from childhood into early adoles-
cence among 22q11.2 deletion carriers who later devel-
oped schizophrenia [71]. In line with our results, others
have also found that worse scores on parent-reported
sociability, peer relations, and interests were signifi-
cantly associated with higher levels of schizotypy symp-
toms in 22q11.2DS [72]. A previous study has also
reported that adolescents with 22q11.2DS and psych-
otic symptoms have more social withdrawal and less
adaptive socialization skills in comparison with young
22q11.2DS individuals without psychotic symptoms
[73]. Taken together, these lines of evidence indicate
that a drop in social functioning and social skills may
predate the onset of psychosis and schizophrenia in
22q11.2DS.
ToM deficits have previously been described for a co-
hort of 22q11.2DS adults with schizophrenia in compari-
son with a 22q11.2DS cohort without schizophrenia
[43]. ToM impairments (mean TASIT z-score of ap-
proximately −1.75 compared to control peers) have also
been reported in a mixed cohort of 22q11.2DS adoles-
cents where some presented with psychotic illness [42].
Jalbrzikowski and collaborators showed that TASIT
scores were correlated with both positive and negative
SIPS symptoms levels. Similarly, we found pronounced
deficits in ToM as well as a strong association between
TASITtotal scores and level of subclinical negative but
not in positive symptoms in our cohort of young
22q11.2DS individuals. We also saw that ToM deficits
were apparent in all three TASIT interaction types, with
the more difficult interaction type (i.e., paradoxical sar-
casm) showing the most significant difference between
22q11.2 deletion carriers and control peers. Due to the
low levels of positive symptoms in the cohort, our data
did not meet the assumption of linearity between TASIT
scores and positive symptom levels. The discrepancies
between our data and the results previous reported by
Jalbrzikowski et al. (2012) on positive symptoms may re-
sult from difference in schizophrenia prevalence between
the two 22q11.2DS cohorts under investigation. In par-
ticular, the average levels of positive symptoms differ by
threefold between the two 22q11.2DS studies.
In line with previous reports [38–41], we found that
the 22q11.2DS group had strong emotional recognition
impairments with difficulties in perceiving emotions
from facial expressions across the panel of negative emo-
tions (i.e., anger, fear, and disgust), but that the ability to
identify expressions of surprise was conserved. In con-
trast to these previous reports, our 22q11.2DS cohort
showed reduced ability to recognize happy facial ex-
pressions. However, the CANTAB ERT test applies
morphed images with fast cover up times to avoid ceil-
ing effects. As a consequence, the CANTAB ERT test
may be more sensitive to more subtle deficits compared
to other emotion recognition tasks, and the inter-study
discrepancies may relate to differences in the tools ap-
plied between studies.
A recent meta-analysis has shown moderate associa-
tions between impairments in emotional recognition,
and the severity of negative symptoms in idiopathic
schizophrenia [74] and findings from the Dutch Genetic
Risk and Outcome in Psychosis (GROUP) study suggest
that social cognitive deficits and negative symptoms are
etiologically related [23]. Although we only observed a
minor association between emotional recognition deficit
and the severity of subclinical negative symptoms, in our
non-psychotic 22q11.2DS group, we did observe a stron-
ger association between the negative symptoms and the
other social cognitive function accessed by TASIT. This
could indicate that there is a shared origin of these phe-
nomenon’s in 22q11.2DS. Moreover, we cannot exclude
the possibility that a pathological progression of negative
symptoms may result in stronger correlations between
these phenomena if some of the 22q11.2 deletion car-
riers develop schizophrenia. This would provide stronger
confirmation on the etiologically relatedness between
the social cognitive deficits and the negative symptoms.
Taken together, these lines of evidence suggest that
22q11.2DS may be a valuable genetic model for schizo-
phrenia per se or for the subgroup of schizophrenia pa-
tients more highly affected by negative symptoms.
Similar to findings in idiopathic schizophrenia, e.g.,
[74], the social impairments in our 22q11.2DS cohort
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were not accounting for all of the variation in symptom
severity. Hence, our results suggest that deficits in other
cognitive functions are contributing to the mechanisms
driving the negative and particular positive symptom-
atology. Moreover, the extended models that included
ABASsocial and SRStotal did not improve the predictability
of the linear models compared to the model for ABASso-
cial alone. This suggests that the effect of social skills on
the negative symptom levels were captured by the meas-
ure of social function (ABASsocial). In contrast, when the
combined effect of both ABASsocial and TASITtotal were
considered the model accounted for a significant greater
proportion of the variation in negative symptoms com-
pared to the model for ABASsocial alone. Together with
the lack of strong inter-relationship between the ABAS-
social rating and the TASITtotal score, this may suggest
that the effect of ToM on the negative symptom levels is
mediated by slightly different mechanisms that are not
fully encompassed within the measure of social function
(ABASsocial).
Clinical implications
Identification of the early signs of schizophrenia is
mandatory for early intervention and prevention strat-
egies in psychiatry. Emerging evidence from studies in
idiopathic schizophrenia suggests that psychosocial in-
terventions are effective in improving functionality
[21, 75–77] and that early intervention may improve
treatment outcome and even reduces the disease tran-
sition rate [78].
From our study, the association between social impair-
ments and subclinical negative and positive symptom
severity emphasizes the importance of clinical awareness
of potential subclinical psychosis symptoms when
caregiver or self-reporting suggests substantial social im-
pairments. Based on these findings, we speculate if psy-
chosocial interventions could be efficient in improving
functioning and perhaps even reduce the severity of
schizophrenia symptoms in 22q11.2DS.
Intervention models for targeted psychosocial training
in 22q11.2DS have already been proposed [79, 80] and
cognitive enhancement therapy of tailored exercises,
which include perspective taking and identification of
non-verbal social clues, has been shown to improve so-
cial cognitive abilities in adolescents with 22q11.2DS
[80]. Also, the training scheme applied by Glaser et al
[79] which targets focusing on the eyes, emotion recog-
nition and understanding, and working memory has
shown short-term improvements in these functions.
However, the long-term effect on psychopathology of
these interventions is still to be evaluated. Due to the
lack of strong correlations between the social cognitive
abilities and the more applied social skills and function-
ing, seen in our study, we speculate if psychosocial
training should target both the cognitive domain and the
applied skills in order to improve the overall functioning
or mitigate symptom severity in 22q11.2DS individuals.
Hence, longitudinal studies that can improve our under-
standing of the underlying mechanisms of social func-
tioning and the relevance of social impairments as early
markers of schizophrenia, as well as potential targets for
psychosocial training in 22q11.2DS are of the essence.
Limitations
Our study showed that social impairments were more
pronounced than negative and positive symptoms in our
22q11.2DS cohort where none of the participants meet
the clinical diagnostic criteria within the schizophrenia
spectrum. However, the cross-sectional study design is
not suited to address the direction of the association be-
tween the social impairments and the subclinical symp-
toms (i.e., if social impairments develop before the onset
of negative and positive symptoms or vice versa?). Des-
pite this limitation, we only observed relatively low
levels of current symptoms among the recruited car-
riers of the 22q11.2 deletion and the associations be-
tween social impairments and negative symptoms were
strong and in the same direction as shown in the previ-
ous reports [42, 71]. However, the robustness of our re-
sults regarding positive symptoms may be diminished
due to sample size limitations. Likewise, the uneven sex
ratio and the skewed between-sex and age distributions
are likely sample size dependent, and although we saw
the same magnitude of social skill deficits as previously
reported for 22q11.2DS [69, 70], we did not observe the
usually reported superior female SRS ratings [81] in
neither 22q11.2DS nor controls. Our results may also
be influenced by the application of one test block only
in the ERT test; nonetheless, overall, our findings of di-
minished emotional recognition deficits were in accord-
ance with results reported by Jalbrzikowski et al. [42]
and more recently in a group of children and adoles-
cents with 22q11.2DS [41].
The measures of social competences, which we have
applied, were not evaluated relative to a negative control
measure (i.e., a cognitive function unrelated to the
symptomatology) and therefore we cannot fully specify
their impact on the negative and positive symptoms.
The area of social functioning is complex and can be
conceptualized and measured as a very important area
of adaptive functioning and as autistic social and com-
municative deficits. Although the reliability and validity
of the Danish translation of the ABAS-II has not been
assessed, ample reliability and validity data are included
in the ABAS-II manual [59]. Moreover, the average rat-
ing score of the 22q11.2DS cohort was more than two
standard derivations below the mean of the control
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group indicating that everyday functioning was indeed
impaired in the cases.
This study has evaluated two central aspects of social
cognitive functions (ToM and emotion recognition). How-
ever, these functions may only reflect part of the multi-
construct domains that they belong to. Other tasks will
probably tap into overlapping or different mentalizing
capacities that are equally important for performance in
the social world and be implicated in negative and positive
symptomatology.
Clinical case–control studies are often affected by as-
certainment bias (i.e., cases being ascertained from sub-
specialty hospital departments and/or control individuals
not being representative of the background population).
However, the case group enrolled in the current study
was not recruited from subspecialty hospital units.
Moreover, based on the clinical profile of lifetime ill-
nesses obtained from the Danish healthcare registries,
we have previously shown that the case group is repre-
sentative of the entire cohort of 22q11.2 deletion carriers
known in Denmark [44]. In contrast, our control partici-
pants are probably more altruistic (i.e., willing to invest
time on something that is not to the benefit of them-
selves) and may have stronger mental resources than the
true community control would have. However, we be-
lieve that this is a general limitation of case–control
studies as such.
Conclusions
We report strong social impairments across three layers
of social functioning, skills, and cognition and correla-
tions between levels of social impairments and subclin-
ical negative and positive symptoms. Albeit longitudinal
studies are required to show if social impairments repre-
sent early disease manifestations, the associations between
social impairments and subclinical positive and negative
symptom severity advocate for clinical awareness of po-
tential subclinical psychosis symptoms when parents and
caregivers report substantial social impairments.
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